Companies/US/BOLD

BOUNDLESS BIO, INC.

Last · NASDAQ$2.39-0.04 (-1.65%)close · yahoo · 15h ago
Vol 129.8K ≈ 310.2K
Market cap$55.23M23.1M sh
P/E · TTM-0.9fwd -2.4 · eps -2.80 · loss
Beta0.47vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.961$3.164
Volume129.8Ksession

Issuer

Legal nameBOUNDLESS BIO, INC.
HQUnited States (US)
ListingUS BOLD
ISINUS10170A1007
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001782303
CIK0001782303
Employees28
AddressBoundless Bio, Inc. North Torrey Pines Road 11099, La Jolla
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-09

From latest 10-K · 2026-03-09

  • Operating Cf Burn
  • Cash Runway Low
  • Accumulated Deficit High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~0.4 years
  • Accumulated Deficit High — Accumulated deficit / equity 263%

Press & signals

1 recent
  • GlobeNewswire

    Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

Documents

FormReporting forFiledFlags
2026-08-262026-08-280
2026-06-302026-08-07 3
2026-07-172026-07-210
2026-07-142026-07-160